ALEXANDRIA, Va., June 9 -- United States Patent no. 12,649,783, issued on June 9, was assigned to IMMUNOMETABOLISM DEVELOPMENT Co. LLC (Lebanon, N.H.).
"Anti-MCT1 antibodies and uses thereof" was invented by Jay L. Rothstein (Norwich, Vt.), Grace Ki Jeong Lee (Simi Valley, Calif.), Kimberly P. Shigenaka (Seattle), Marcia Gordon (Seattle), Kim Quon (Seattle), Philipe Gobeil (Toronto), Catherine Carriere (Lebanon, N.H.) and Sergey Seregin (Lebanon, N.H.).
According to the abstract* released by the U.S. Patent & Trademark Office: "This invention generally pertains to antibodies and antigen-binding fragments thereof, e.g., humanized, chimeric, and human antibodies and antigen-binding fragments thereof, and fusion proteins, compositions contai...